Jazz Phamaceuticals tiene un Precio Actual de 145 ,29 $ . Analistas de EEUU le Suben el Precio Objetivo hasta los $171 con una Recomendación de Comprar ... " Gracias al Posible Potencial del Zepsyre® para el Tratamiento de SMALL CELL LUNG CANCER " .

247wallst.com / investing .

... Many investors still have not made portfolio changes since the very strong market in 2019. This is also an election year in which much is at stake, and strategists overall are calling for single-digit percentage gains in 2020.

24/7 Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding new ideas for traders and long-term investors alike. Some of the daily analyst calls cover stocks to buy, while some calls cover stocks to sell or to avoid. ...

Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) was Reiterated as Buy and the Target Price was Raised to $171 from $166 (versus a $145.29 close) at SunTrust Robinson Humphrey.

The Firm Believes its Small-Cell Lung Cancer Could be Approved in the Second Half of this Year and that Lurbinectedin has Significant Market Potential .